This page shows the latest Ledaga news and features for those working in and with pharma, biotech and healthcare.
Still need to meet CHMP post-approval requirements. Actelion has won EU approval for Ledaga, a drug to treat a rare form of lymphoma that manifests itself in the skin, but ... The Swiss biotech - which already sells Ledaga (mechlorethamine or chlormethine
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...